Treatment of EGFR WT cells co-expressing EGFRvIII with EGF dissociates the E3 ligase-RIP complex, resulting in cell death. Critically, loss of RIPK1 abrogates the tumour-forming capability of these cells in an in vivo orthotopic model of GB. This evidence concerns the gene RIPK1 and neoplasm.